Revelation Biosciences, Inc. (REVB): Capital Expenditures

Annual figures by period end, from SEC filings.

$19.2K

Year ended 2024-12-31

-47.4%

3-year compound annual growth

2021-12-31 Capital Expenditures (USD) 2024-12-31

Period ended	Capital Expenditures	Change YoY	Source filing
2024-12-31	$19.2K	n/a	2026-02-26, From 2024-01-01
No annual figure between 2021-12-31 and 2024-12-31.
2021-12-31	$132.0K	n/a	2023-03-30, From 2021-01-01